Camphor 0.001 MG/MG / diphenhydramine hydrochloride 0.02 MG/MG / zinc acetate 0.01 MG/MG T... — RxCUI 2263170
RxNorm drug concept · Semantic clinical drug
RxCUI 2263170
Semantic clinical drug · SCD
● Current RxNorm concept 2 FDA products
6 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2263170
Official nameCamphor 0.001 MG/MG / diphenhydramine hydrochloride 0.02 MG/MG / zinc acetate 0.01 MG/MG Topical Gel
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascamphor 0.1 % / diphenhydramine HCl 2 % / zinc acetate 1 % Topical Gel; camphor 0.001 MG/MG / diphenhydramine HCl 0.02 MG/MG / zinc acetate 0.01 MG/MG Topical Gel
FDA products mapped2
Package NDCs mapped6
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Diphenhydramine Topical: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- You can use it for temporary relief of pain and itching from everyday skin problems — things like insect bites, minor burns, minor cuts and scrapes, and general skin irritations. I...
- What can I actually use this cream or spray for?
- You can apply it up to 3 to 4 times a day, but no more than that. More frequent use isn't going to help more — and the label is clear that you shouldn't exceed that limit. For kids...
- This is really important — do not use this topical product at the same time as any other product that contains diphenhydramine, even a pill or capsule. That includes allergy medici...
🕸️ Concept Web — How Camphor 0.001 MG/MG / diphenhydramine hydrochlor... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Camphor 0.001 MG/MG / diphenhydramine hydrochloride 0.02 MG/MG / zinc acetate 0.01 MG/MG Topical Gel
RxCUI 2263170 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 5
The active substance itself — no strength, form, or brand attached yet.
-
Camphor
1952IN -
Diphenhydramine
3498IN -
Zinc acetate
58295IN -
Camphor / diphenhydramine / zinc acetate
2263169MIN -
Diphenhydramine hydrochloride
1362PIN
-
Camphor
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Camphor / diphenhydramine / zinc acetate Topical Gel
2263168SCDF -
Camphor / diphenhydramine hydrochloride / zinc acetate Topical Gel
2648902SCDFP -
Camphor / diphenhydramine / zinc acetate Topical Product
2263167SCDG -
Camphor / diphenhydramine hydrochloride / zinc acetate Topical Product
2659113SCDGP -
Topical Gel
346286DF -
Topical Product
1151122DFG
-
Camphor / diphenhydramine / zinc acetate Topical Gel
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Camphor 0.001 MG/MG
1440015SCDC -
Diphenhydramine hydrochloride 0.02 MG/MG
1049088SCDC -
Zinc acetate 0.01 MG/MG
334322SCDC
-
Camphor 0.001 MG/MG
Showing up to 8 concepts per family — 14 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Camphor 0.001 MG/MG
SCDC · 1440015 -
Diphenhydramine hydrochloride 0.02 MG/MG
SCDC · 1049088 -
Zinc acetate 0.01 MG/MG
SCDC · 334322 -
Camphor / diphenhydramine / zinc acetate Topical Gel
SCDF · 2263168 -
Camphor / diphenhydramine hydrochloride / zinc acetate Topical Gel
SCDFP · 2648902 -
Camphor / diphenhydramine / zinc acetate Topical Product
SCDG · 2263167 -
Camphor / diphenhydramine hydrochloride / zinc acetate Topical Product
SCDGP · 2659113
📦 FDA Products & Package NDCs
2 products · 6 package NDCs
6 package NDCs map to RxCUI 2263170 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 65753-0400-02 | 59 mL in 1 BOTTLE (65753-400-02) | CoreTex Anti-Itch Gel | CoreTex Products Inc | 2019-11-26 |
| 65753-0400-04 | 177 mL in 1 BOTTLE (65753-400-04) | CoreTex Anti-Itch Gel | CoreTex Products Inc | 2019-11-26 |
| 65753-0400-13 | 25 POUCH in 1 CONTAINER (65753-400-13) / 1 mL in 1 POUCH | CoreTex Anti-Itch Gel | CoreTex Products Inc | 2019-11-26 |
| 65753-0400-14 | 300 POUCH in 1 CONTAINER (65753-400-14) / 1 mL in 1 POUCH | CoreTex Anti-Itch Gel | CoreTex Products Inc | 2019-11-26 |
| 65753-0514-35 | 1 KIT in 1 KIT (65753-514-35) * 4.44 mL in 1 APPLICATOR (6... | CoreTex Professional Outdoor Skin Protection Wallet | CoreTex Products Inc | 2023-02-24 |
| 65753-0514-36 | 1 KIT in 1 KIT (65753-514-36) * 4.44 mL in 1 APPLICATOR (6... | CoreTex Professional Outdoor Skin Protection Wallet | CoreTex Products Inc | 2023-02-24 |
Observed labelers:
CoreTex Products Inc (6)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.